Actions du secteur de la santé
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1003 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.01 USD | -3.69% | -1.36% | +12.27% | +41.09% | 8.42 B USD | ||
| 1009 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 129.89 USD | -1.16% | -2.04% | +18.08% | +72.89% | 8.35 B USD | ||
| 1012 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.82 USD | +0.13% | +0.25% | +49.25% | +149.71% | 8.28 B USD | ||
| 1016 |  PCVX Vaxcyte, Inc. - Common Stock | 57.03 USD | -2.03% | -1.30% | +19.53% | +34.82% | 8.23 B USD | ||
| 1024 |  RGEN Repligen Corporation - Common Stock | 144.88 USD | +0.44% | +0.21% | +8.35% | -12.56% | 8.17 B USD | ||
| 1025 |  IBRX ImmunityBio, Inc. - Common Stock | 7.79 USD | -5.23% | -13.06% | +7.45% | +166.78% | 8.16 B USD | ||
| 1026 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 93.73 USD | -4.10% | +5.46% | +14.91% | +292.01% | 8.14 B USD | ||
| 1031 |  HQY HealthEquity, Inc. - Common Stock | 95.66 USD | +1.33% | -2.16% | +7.76% | -1.00% | 8.00 B USD | ||
| 1035 |  ATR AptarGroup, Inc. Common Stock | 124.90 USD | -0.51% | -1.51% | +5.72% | -20.69% | 7.97 B USD | ||
| 1036 |  BIO Bio-Rad Laboratories, Inc. Class A Common Stock | 297.56 USD | +0.48% | -0.36% | +2.96% | -11.62% | 7.96 B USD | ||
| 1041 |  IMVT Immunovant, Inc. - Common Stock | 38.70 USD | -2.54% | -0.77% | +14.50% | +101.46% | 7.95 B USD | ||
| 1065 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 60.94 USD | -3.94% | -3.73% | +17.76% | +53.69% | 7.62 B USD | ||
| 1081 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.49 USD | -0.84% | -4.88% | +15.58% | -2.56% | 7.37 B USD | ||
| 1088 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 119.04 USD | -2.53% | -3.69% | +19.65% | +69.74% | 7.26 B USD | ||
| 1120 |  LNTH Lantheus Holdings, Inc. - Common Stock | 105.39 USD | -0.24% | +3.83% | +0.59% | +88.00% | 6.86 B USD | ||
| 1122 |  PACS PACS Group, Inc. Common Stock | 43.29 USD | +0.12% | -4.12% | +16.59% | +236.89% | 6.85 B USD | ||
| 1156 |  SRRK Scholar Rock Holding Corporation - Common Stock | 54.70 USD | -3.54% | -1.48% | +22.07% | +82.21% | 6.55 B USD | ||
| 1159 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.72 USD | -1.74% | +10.83% | +29.88% | +66.02% | 6.55 B USD | ||
| 1161 |  CHE Chemed Corp | 492.28 USD | +0.80% | +1.43% | +17.61% | +6.45% | 6.53 B USD | ||
| 1176 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.46 USD | -3.63% | -6.12% | +12.16% | +139.06% | 6.40 B USD |
Nouvelles Actions du secteur de la santé
S&P Global améliore les perspectives de Revvity grâce à la réduction de l’endettement
Glencore convertit une débenture de 25 millions $ dans Osisko Metals
Stifel initie une couverture d’Arrowhead Pharma avec une note d’achat
Dexcom obtient l’autorisation de Santé Canada pour le G7 15 Day
Dexcom reçoit l'autorisation de Santé Canada pour le système de CGM Dexcom G7 15 jours, offrant un port de 15,5 jours, une précision MARD de 8,0 % et moins de changements de capteurs pour les Canadiens atteints de diabète. | Benzinga France
Pourquoi l’action Erasca chute-t-elle aujourd’hui ?
Astrana Health nomme des dirigeants pour son activité médicale et sa transformation
Gainers Actions du secteur de la santé
 XAIR Beyond Air, Inc. - Common Stock | 7.49 | +1683.33% |
 QTTB Q32 Bio Inc. - Common Stock | 21.38 | +90.72% |
 AGEN Agenus Inc. - Common Stock | 6.12 | +82.69% |
 SRXH SRX Health Solutions, Inc. Common Stock | 2.78 | +31.13% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.50 | +23.97% |
 TOIIW The Oncology Institute, Inc. - Warrant | 0.0597 | +19.64% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0239 | +19.50% |
 GALT Galectin Therapeutics Inc. - Common Stock | 4.60 | +13.30% |
Losers Actions du secteur de la santé
 MTNB Matinas Biopharma Holdings, Inc. Common Stock | 0.49 | -33.78% |
 AEON AEON Biopharma, Inc. Class A Common Stock | 0.32 | -33.33% |
 LUCYW Innovative Eyewear, Inc. - Warrants | 0.0537 | -29.34% |
 BIVI BioVie Inc. - Common stock | 1.64 | -27.75% |
 ZCMD Zhongchao Inc. - Class A Ordinary Shares | 1.51 | -25.62% |
 APLM Apollomics Inc. - Class A Ordinary Shares | 14.21 | -25.01% |
 HUMAW Humacyte, Inc. - Warrant | 0.0076 | -24.00% |
 AARD Aardvark Therapeutics, Inc. - Common Stock | 5.96 | -21.58% |